Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo upon post-ovulatory administration in fertile women

References

• Gemzell-Danielsson K, Meng CX. Emergency contraception: potential role of ulipristal acetate. Int J Womens Health. 2010;2:53–615.
   PubMedGoogle Scholar
• Brache V, Cochon L, Jesam C, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod. 2010;25(9):2256–2263.
   PubMedGoogle Scholar
• Gemzell-Danielsson K, Berger C, Lalitkumar PG. Mechanisms of action of oral emergency contraception. Gynecol Endocrinol. 2014;30(10):685–687.
   PubMed Web of Science ®Google Scholar
• Fine P, Mathé H, Ginde S, et al. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115(2 Pt 1):257–263.
   PubMed Web of Science ®Google Scholar
• Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and Meta-analysis. Lancet. 2010;375(9714):555–562.
   PubMed Web of Science ®Google Scholar
• Mozzanega B, Cosmi E, Nardelli GB. Ulipristal acetate in emergency contraception: mechanism of action. Trends Pharmacol Sci. 2013;34(4):195–196.
   PubMedGoogle Scholar
• Mozzanega B, Gizzo S, Di Gangi S, et al. Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception. Reprod Sci. 2014;21(6):678–685.
   PubMedGoogle Scholar
• Munuce MJ, Gómez-Elías MD, Caille AM, et al. Mechanisms involved in the contraceptive effects of ulipristal acetate. Reproduction. 2020;159(3):R139–R149.
   PubMedGoogle Scholar
• Gómez-Elías MD, May M, Munuce MJ, et al. A single post-ovulatory dose of ulipristal acetate impairs post-fertilization events in mice. Mol Hum Reprod. 2019;25(5):257–264.
   PubMedGoogle Scholar
• Li HWR, Resche-Rigon M, Bagchi IC, et al. Does ulipristal acetate emergency contraception (ella®) interfere with implantation? Contraception. 2019;100(5):386–390.
   PubMedGoogle Scholar
• Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340(23):1796–1799.
   PubMed Web of Science ®Google Scholar
• Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50–60.
   PubMed Web of Science ®Google Scholar
• Carrascosa JP, Cotan D, Jurado I, et al. The effect of copper on endometrial receptivity and induction of apoptosis on decidualized human endometrial stromal cells. Reprod Sci. 2018;25(7):985–999.
   PubMedGoogle Scholar
• Batzer F. Ultrasonic indices of ovulation. J Reprod Med. 1986;31(8 Suppl):764–769.
   PubMedGoogle Scholar
• Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
   PubMed Web of Science ®Google Scholar
• Blithe DL, Nieman LK, Blye RP, et al. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids. 2003;68(10-13):1013–1017.
   PubMed Web of Science ®Google Scholar
• Stratton P, Hartog B, Hajizadeh N, et al. A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod. 2000;15(5):1092–1099.
   PubMed Web of Science ®Google Scholar
• Stratton P, Levens ED, Hartog B, et al. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril. 2010;93(6):2035–2041.
   PubMed Web of Science ®Google Scholar
• Altmäe S, Koel M, Võsa U, et al. Meta-signature of human endometrial receptivity: a Meta-analysis and validation study of transcriptomic biomarkers. Sci Rep. 2017;7(1):10077.
   PubMedGoogle Scholar
• Qu W, Zhao Y, Wang X, et al. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. Clin Chim Acta. 2019;489:225–232.
   PubMedGoogle Scholar
• Berger C, Boggavarapu NR, Menezes J, et al. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system. Hum Reprod. 2015;30(4):800–811.
   PubMedGoogle Scholar
• Lira-Albarrán S, Durand M, Larrea-Schiavon MF, et al. Ulipristal acetate administration at mid-cycle changes gene expression profiling of endometrial biopsies taken during the receptive period of the human menstrual cycle. Mol Cell Endocrinol. 2017;447:1–11.
   PubMed Web of Science ®Google Scholar
• Lira-Albarrán S, Durand M, Barrera D, et al. A single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycle. Mol Cell Endocrinol. 2018;476:70–78.
   PubMedGoogle Scholar
• Sugino N, Kashida S, Karube-Harada A, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction. 2002;123(3):379–387.
   PubMedGoogle Scholar
• Lam KK, Chiu PC, Chung MK, et al. Glycodelin-A as a modulator of trophoblast invasion. Hum Reprod. 2009;24(9):2093–2103.
   PubMed Web of Science ®Google Scholar
• Fallah A, Mohammad-Hasani A, Colagar AH. Zinc is an essential element for male fertility: a review of Zn roles in men's health, germination, sperm quality, and fertilization. J Reprod Infertil. 2018;19(2):69–81.
   PubMedGoogle Scholar
• Courtoy GE, Henriet P, Marbaix E, et al. Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment. J Clin Endocrinol Metab. 2018;103(4):1566–1573.
   PubMedGoogle Scholar
• Kolanska K, Varinot J, Canlorbe G, et al. Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium. Reprod Biomed Online. 2019;38(5):825–834.
   PubMedGoogle Scholar